INFO for PRESENTERS

 

Oral Presentations

Presenters using Powerpoint (or equivalent software) presentation should bring it on memory stick (USB connected), CD or DVD, and load it in the designated computer between 7:30-8:15 (morning sessions) or 13:00-14:00 (afternoon sessions).

Presenters combining Powerpoint and video films are requested to double-check their presentations before the sessions to be sure they work properly.

Please note that PCs in the session hall will be provided with Office 2010.

Macintosh will be also available. Alternatively, MAC users can bring their own computer and a VGA adaptor.

 

Poster Presentations

Posters will be on display in two sessions. Posters must be mounted by 10:00 on the day of their presentation, and must remain on display until the end of the day (19:00 hours). Posters presenters are requested to stand by their posters for informal discussion during the designated poster session and during the coffee breaks on the day of presentation. Posters left after the end of the sessions each day will be removed and discarded. AOPT 2013 is not responsible for poster materials left at meeting’s end.

Please read the Poster Presentation Guidelines.

 

Poster Session 1: Friday, February 8, 17:45–19:00 – Poster Numbers: P1.01 to P1.16
Topics
Corneal and ocular surface pharmacology and therapeutics
Imaging and therapy monitoring (cornea)
Pharmacokinetics and sustained drug delivery (cornea)
Poster Session 2: Saturday, February 9, 17:45–19:00 – Poster Numbers: P2.01 to P2.16
Topics
Clinic meets research: aspects of translational sciences
Drugs and Ocular blood flow
Imaging and therapy monitoring
New ophthalmic uses for existing drugs
New strategies for neuroprotection and regeneration in glaucoma
New treatments for retinal disease
Novel drugs and devices for IOP lowering
Pharmacokinetics and sustained drug delivery

 

Disclosures

 

All Commercial Relationships must be indicated on the poster (even if they were not indicated at abstract submission). Commercial Relationships description must include the name(s) of the company(s) with which a commercial relationship exists, conflicts of interest, and/or patents or patent applications, associated with the abstract at the time of their presentation. Indicate ‘None’ when applicable.

Recording Policy

Recording (photographing, audiotaping, or videotaping) any presentation or poster is PROHIBITED, except by an authors who want to photograph their presentations.

16 January 2013